Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-23T22:28:36.531Z Has data issue: false hasContentIssue false
  • English
  • Français

Polymyalgia rheumatica

Published online by Cambridge University Press:  17 November 2008

HA Bird
HA Bird*
Affiliation:
The Leeds General Infirmary and the Royal Bath Hospital, Harrogate, UK
*
HA Bird, The Clinical Pharmacology Unit, Royal Bath Hospital, Cornwall Road, Harrogate HG1 2PS, UK.
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Clinical geriatrics
Information
Reviews in Clinical Gerontology , Volume 3 , Issue 1 , February 1993 , pp. 31 - 38
Copyright
Copyright © Cambridge University Press 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Bird, HA. Polymyalgia rheumatica and temporal arteritis. In: Wright, V ed. Bone and joint disease in the elderly. Edinburgh: Churchill Livingstone. 1983: 60–79.Google Scholar
2Bird, HA.Symposia report, British Society for Rheumatology Annual General Meeting: polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1988; 27: 310–16.CrossRefGoogle Scholar
3Bruce, W.Senile rheumatic gout. Br Med J 1888; 2: 811–13.CrossRefGoogle ScholarPubMed
4Barber, HS.Myalgic syndrome with constitutional effects; polymyalgia rheumatica. Ann Rheum Dis 1957; 16: 230–37.CrossRefGoogle ScholarPubMed
5Hutchinson, J.On a peculiar form of thrombotic arteritis of the aged which is sometimes productive of gangrene. Arch Surg 1890; 1: 323–29.Google Scholar
6Paulley, JW, Hughes, JP.Giant cell arteritis or arteritis of the aged. Br Med J 1960; 2: 1562–67.CrossRefGoogle ScholarPubMed
7Bird, HA, Esselinckx, W, Dixon, AStJ, Mowat, AG, Wood PHN. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 434–39.CrossRefGoogle Scholar
8Wilke, WS, Wysenbeek, AJ, Krall, PL, Segal, AM.Masked presentation of giant cell arteritis. Cleve Clin Q 1985; 52: 155–59.CrossRefGoogle ScholarPubMed
9Jones, JG, Hazleman, GL.Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981; 40: 1–5.Google Scholar
10Nobunaga, M, Yoshioka, K, Yasuada, M, Shingu, M. A proposal of diagnostic criteria for polymyalgia rheumatica. XVIIth ILAR Congress of Rheumatology, Rio de Janeiro, Brazil. 1989: abstract W81.Google Scholar
11Mowat, AG, Hazleman, BL.Polymyalgia rheumatica – a clinical study with particular reference to arterial disease. J Rheumatol 1974; 1: 190–202.Google Scholar
12Chuang, T, Hunder, GG, Ilstrup, DM, Kurland, LT.Polymyalgia rheumatica: a 10 year epidemiologic and clinical study. Ann Intern Med 1982; 97: 672–80.CrossRefGoogle ScholarPubMed
13Salvarani, C, Macchioni, PL, Tartoni, PLet al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987; 5: 205–15.Google Scholar
14Fauchald, P, Rygvold, O, Oystese, B. Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings. Ann Intern Med 1972; 77: 845–52.Google Scholar
15Allison, MC.Temporal artery biopsy. Br Med J 1988; 297: 933–34.CrossRefGoogle ScholarPubMed
16Cimmino, MA, Caporali, R, Montecucco, CM, Rovida, S, Baratelli, E, Broggini, M.A seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis 1990; 49: 521–23.CrossRefGoogle ScholarPubMed
17Kyle, V, Tudor, J, Wraight, P, Gresham, GA, Hazleman, BL.Rarity of synovitis in polymyalgia rheumatica. Ann Rheum Dis 1990; 49: 155–57.CrossRefGoogle ScholarPubMed
18Sonnenblick, M, Nesher, G, Rosin, A. Non-classical organ involvement in temporal arteritis. Semin Arthritis Rheum 1989; 19: 183–90.CrossRefGoogle Scholar
19Nordborg, E, Bengtsson, B-A. Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy. Br Med J 1989; 299: 549–50.CrossRefGoogle ScholarPubMed
20McKendry, RJR, Guindi, M, Hill, DP.Giant cell arteritis (temporal arteritis) affecting the breast: a report of two cases and a review of published reports. Ann Rheum Dis 1990; 49: 1001–1004.CrossRefGoogle Scholar
21Silveira, LH, Jara, U, Martinez-Osuna, P, Espinoza, LR.Polymyalgia rheumatica: a report of a case with severe synovitis (synovial cysts). Ann Rheum Dis 1992; 51: 430–31.Google Scholar
22McAlindon, TE, Ferguson, IT.Mononeuritis multiplex and occipital infarction complicating giant cell arteritis. Br J Rheumatol 1989; 28: 257–58.Google Scholar
23Laidlaw, DAH, Smith, PEM, Hudgson, P.Orbital pseudotumour secondary to giant cell arteritis: an unreported condition. Br Med J 1990; 300: 784.Google Scholar
24Brelsford, WG, Goodman, RE.Effect of hemiparesis on polymyalgia rheumatica. J Rheumatol 1988; 15: 1433–34.Google Scholar
25Healey, LA.Polymyalgia rheumatica and the American Rheumatism Association criteria for rheumatoid arthritis. Arthritis Rheum 1983; 26: 1417–18.Google Scholar
26Robbins, DL, White, RH.Inter-relationships between polymyalgia rheumatica and polyarthritis. J Rhewnatol 1988; 15: 1323–25.Google Scholar
27Healey, LA. Late-onset RA vs polymyalgia rheumatica. Geriatr Med 1989; 02: 59–65.Google Scholar
28Häntzschel, H, Bird, HA, Seidel, Wet al. Polymyalgia rheumatica and rheumatoid arthritis of the elderly: a clinical, laboratory and scintigraphic comparison. Ann Rheum Dis 1991; 50: 619–22.CrossRefGoogle ScholarPubMed
29Wiseman, P, Stewart, K, Rai, GS.Hyperthyroidism in polymyalgia rheumatica and giant cell arteritis. Br Med J 1989; 298: 647–48.CrossRefGoogle Scholar
30Bowness, P, Shotliff, K, Middlemiss, A, Myles, AB.Prevalence of hyperthyroidism in patients with polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1991; 30: 349–51.CrossRefGoogle Scholar
31Mallya, RK, Hind, CRK, Berry, H, Pepys, MB.Serum C-reactive protein in polymyalgia rheumatica. Aprospective serial study. Arthritis Rheum 1985; 28: 383–87.CrossRefGoogle Scholar
32Kyle, V, Cawston, TE, Hazleman, BL.Erythrocyte sedimentation rate and C-reactive protein in the assessment of polymyalgia rheumaticalgiant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989; 48: 667–71.Google Scholar
33Hachulla, E, Salle, R, Parra, HJet al. Serum amyloid A concentrations in giant cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease. Clin Exp Rheumatol 1991; 9: 157–63.Google ScholarPubMed
34Dasgupta, B, Duke, O, Kyle, V, Macfarlane, DG, Hazleman, BL, Panayi, GS.Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Ann Rheum Dis 1987; 46: 746–49.Google Scholar
35Dasgupta, B, Duke, O, Timms, AM, Pitzalis, C, Panayi, GS.Selective depletion and activation of CD8 + lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1989; 48: 307–11.CrossRefGoogle ScholarPubMed
36Hällgren, R, Gudbjörnsson, B, Larsson, E, Fredens, K.Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis. Ann Rheum Dis 1991; 50: 946–49.Google Scholar
37Dasgupta, B, Panayi, GS.Interleukin 6 in serum of patients with polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol 1990; 29: 456–58.CrossRefGoogle ScholarPubMed
38Pountain, G, Hazleman, BL.Soluble IL2 receptors (sIL2r) in polymyalgia rheumatica and giant cell arteritis (PMR/GCA) and during prednisolone treatment per se. Br J Rheumatol 1992; 31 (suppl 1): 7.Google Scholar
39Hunder, G.Immunogenetics and polymyalgia rheumatica. Br J Rheumatol 1990; 29: 321–24.CrossRefGoogle ScholarPubMed
40Sakkas, LI, Loqueman, N, Panayi, GS, Welsh, KI.HLA-DRB, -DQA, -DQB gene polymorphisms in polymyalgia rheumatica. Br J Rheumatol 1989; 18 (suppl 2): 50.Google Scholar
41Shawe, DJ, Gumpel, JM, Reeve, J, Hesp, R, Katz, D, McNally, E.Osteoporosis in polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). Br J Rheumatol 1989; 28 (suppl 1): 29.Google Scholar
42Kyle, V, Hazleman, BL.Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis 1989; 48: 658–61.CrossRefGoogle ScholarPubMed
43Kyle, V, Hazleman, BL.Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side-effects. Ann Rheum Dis 1989; 48: 662–66.CrossRefGoogle ScholarPubMed
44Delecoeuilleri, G, Jolly, P, Cohen, DE, Lan, A, Paolaggi, JB.Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients). Ann Rheum Dis 1988; 47: 733–39.Google Scholar
45Watts, MT, Nelson, ME, Rennie, IG.Treatment of polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 1990; 49: 568–69.Google Scholar
46Myles, AB, Perera, T, Ridley, MG.Prevention of blindness in giant cell arteritis by corticosteroid treatment. Br J Rheumatol 1992; 31: 103–105.CrossRefGoogle ScholarPubMed
47Kyle, V, Hazleman, BL.Stopping steroids in polymyalgia rheumatica and giant cell arteritis. Br Med J 1990; 300: 344–45.Google Scholar
48Dasgupta, B, Gray, J, Fernandes, L, Olliff, C.Treatment of polymyalgia rheumatica with intra-muscular injections of depot methyiprednisolone. Ann Rheum Dis 1991; 50: 942–45.Google Scholar
49De, Silva M, Hazleman, BL.Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 1986; 45: 136–38.Google Scholar
50Doury, P, Pattin, S, Eulry, F, Thabaut, A.The use of dapsone in the treatment of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 1983; 26: 689–90.Google Scholar